Why prevent, diagnose and treat congenital toxoplasmosis?

Congenital and Maternal Toxoplasmosis

(2010) Jacques Couvreur et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Risk Factors for Retinochoroiditis During the First 2 Years of Life in Infants With Treated Congenital Toxoplasmosis

(2009) François Kieffer et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Longitudinal Study of New Eye Lesions in Children with Toxoplasmosis Who Were Not Treated During the First Year of Life

(2008) Laura Phan et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

In Vitro Susceptibility of Various Genotypic Strains of Toxoplasma gondii to Pyrimethamine, Sulfadiazine, and Atovaquone

(2008) P. Meneceur et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Toxoplasmosis-Associated Neovascular Lesions Treated Successfully With Ranibizumab and Antiparasitic Therapy

(2008) Joseph D. Benevento   ARCHIVES OF OPHTHALMOLOGY

Clinical Practice: Management ofToxoplasma gondiiInfection during Pregnancy

(2008) Jose G. Montoya et al.   CLINICAL INFECTIOUS DISEASES

Predictors of Retinochoroiditis in Children With Congenital Toxoplasmosis: European, Prospective Cohort Study

(2008) K. Freeman et al.   PEDIATRICS

Genetic and Epigenetic Factors at COL2A1 and ABCA4 Influence Clinical Outcome in Congenital Toxoplasmosis

(2008) Sarra E. Jamieson et al.   PLoS One

Novel Triazine JPC-2067-B Inhibits Toxoplasma gondii In Vitro and In Vivo

(2008) Ernest J. Mui et al.   PLoS Neglected Tropical Diseases

Ocular Sequelae of Congenital Toxoplasmosis in Brazil Compared with Europe

(2008) Ruth E. Gilbert et al.   PLoS Neglected Tropical Diseases

Longitudinal Study of New Eye Lesions in Treated Congenital Toxoplasmosis

(2007) Laura Phan et al.   OPHTHALMOLOGY